Published online before print August 21, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,,1
* AIDS Immunophatogenesis Unit, Department of Immunology and Infectious Diseases and
Molecular Genetics Unit, Department of Molecular Biology and Functional Genomics, San Raffaele Scientific Institute, and
Vita-Salute University, School of Medicine, Via Olgettina n. 58, 20132 Milan, Italy
1 Correspondence: P2-P3 Laboratories, DIBIT, Via Olgettina 58, 20132, Milano, Italy. Tel.: 39-02-2643-4909; Fax: 39-02-2643-4905; E-mail: poli.guido{at}hsr.it
The binding of urokinase-type plasminogen activator (uPA) to its glycosyl-phosphatidyl-inositol (GPI) anchored receptor (uPAR) mediates a variety of functions in terms of vascular homeostasis, inflammation and tissue repair. Both uPA and uPAR, as well as their soluble forms detectable in plasma and other body fluids, represent markers of cancer development and metastasis, and they have been recently described as predictors of human immunodeficiency virus (HIV) disease progression, independent of CD4+ T cell counts and viremia. A direct link between the uPA/uPAR system and HIV infection was earlier proposed in terms of cleavage of gp120 envelope by uPA. More recently, a negative regulatory effect on both acutely and chronically infected cells has been linked to the noncatalytic portion of uPA, also referred to as the amino-terminal fragment (ATF). ATF has also been described as a major CD8+ T cell soluble HIV suppressor factor. In chronically infected promonocytic U1 cells this inhibitory effect is exerted at the very late stages of the virus life cycle, involving virion budding and entrapment in intracytoplasmic vacuoles, whereas its mechanism of action in acutely infected cells remains to be defined. Since uPAR is a GPI-anchored receptor it requires association with a signaling-transducing component and different partners, which include CD11b/CD18 integrin and a G-protein coupled receptor homologous to that for the bacterial chemotactic peptide formyl-methionyl-leucyl-phenylalanine. Which signaling coreceptor(s) is(are) responsible for uPA-dependent anti-HIV effect remains currently undefined.
Key Words: macrophage • lymphocyte • interferon
This article has been cited by other articles:
 |
|
 |
|
  V. D'mello, S. Singh, Y. Wu, and R. B. Birge The Urokinase Plasminogen Activator Receptor Promotes Efferocytosis of Apoptotic Cells J. Biol. Chem., June 19, 2009; 284(25): 17030 - 17038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Darnell, W. A. Schroder, J. Gardner, D. Harrich, H. Yu, R. L. Medcalf, D. Warrilow, T. M. Antalis, S. Sonza, and A. Suhrbier SerpinB2 Is an Inducible Host Factor Involved in Enhancing HIV-1 Transcription and Replication J. Biol. Chem., October 20, 2006; 281(42): 31348 - 31358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Roxstrom-Lindquist, E. Ringqvist, D. Palm, and S. Svard Giardia lamblia-Induced Changes in Gene Expression in Differentiated Caco-2 Human Intestinal Epithelial Cells Infect. Immun., December 1, 2005; 73(12): 8204 - 8208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Shushakova, G. Eden, M. Dangers, J. Zwirner, J. Menne, F. Gueler, F. C. Luft, H. Haller, and I. Dumler The Urokinase/Urokinase Receptor System Mediates the IgG Immune Complex-Induced Inflammation in Lung J. Immunol., September 15, 2005; 175(6): 4060 - 4068. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Collman, C.-F. Perno, S. M. Crowe, M. Stevenson, and L. J. Montaner HIV and cells of macrophage/dendritic lineage and other non-T cell reservoirs: new answers yield new questions J. Leukoc. Biol., November 1, 2003; 74(5): 631 - 634. [Abstract] [Full Text] [PDF]
|
|
